ConductScience.org, home

Paper29664013

β-Catenin-mediated immune evasion pathway frequently operates in primary cutaneous melanomas.

Nsengimana J and 17 others. J Clin Invest, 2018. Cited by 83 papers, by iCite.

Cite this record

ConductScience Library. β-Catenin-mediated immune evasion pathway frequently operates in primary cutaneous melanomas. Papers, record 29664013. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29664013

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
β-Catenin-mediated immune evasion pathway frequently operates in primary cutaneous melanomas.
PubMed
Journal
J Clin Invest
PubMed
Year
2018
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
83
iCite
Relative citation ratio, by iCite
2.24
iCite
Revised in PubMed
2025-05-30
PubMed

Authors18

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nsengimana JJérémie
2Laye JJon
3Filia AAnastasia
4O'Shea SSally
5Muralidhar SSathya
6Poźniak JJoanna
7Droop AAlastair
8Chan MMay
9Walker CChristy
10Parkinson LLouise
11Gascoyne JJoanne
12Mell TTracey
13Polso MMinttu
14Jewell RRosalyn
15Randerson-Moor JJuliette
16Cook GPGraham P
17Bishop DTD Timothy
18Newton-Bishop JJulia

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GTP PhosphohydrolasesMajor topic
MelanomaMajor topic
Membrane ProteinsMajor topic
MutationMajor topic
Proto-Oncogene Proteins B-rafMajor topic
Skin NeoplasmsMajor topic
Tumor MicroenvironmentMajor topic
beta CateninMajor topic
Female
Humans
Male

Source PubMed

Download CSV of topics

Grants7

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
MR/M019012/1Medical Research CouncilUnited KingdomPubMed
19167Cancer Research UKUnited KingdomPubMed
11963Cancer Research UKUnited KingdomPubMed
10589Cancer Research UKUnited KingdomPubMed
MR/L01629X/1Medical Research CouncilUnited KingdomPubMed
MR/S00386X/1Medical Research CouncilUnited KingdomPubMed
G0802123Medical Research CouncilUnited KingdomPubMed

Source PubMed

Download CSV of grants

References62

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127660706A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma.J Immunother Cancer2016https://conductscience.org/library/papers/27660706PubMed
225399551Improved overall survival in melanoma with combined dabrafenib and trametinib.N Engl J Med2015https://conductscience.org/library/papers/25399551PubMed
324258985Tumor-infiltrating lymphocytes and their significance in melanoma prognosis.Methods Mol Biol2014https://conductscience.org/library/papers/24258985PubMed
42540308725-Hydroxyvitamin D2 /D3 levels and factors associated with systemic inflammation and melanoma survival in the Leeds Melanoma Cohort.Int J Cancer2015https://conductscience.org/library/papers/25403087PubMed
52593166Model predicting survival in stage I melanoma based on tumor progression.J Natl Cancer Inst1989https://conductscience.org/library/papers/2593166PubMed
623424623Arginase II expressed in cancer-associated fibroblasts indicates tissue hypoxia and predicts poor outcome in patients with pancreatic cancer.PLoS One2013https://conductscience.org/library/papers/23424623PubMed
727525433Tumor immune profiling predicts response to anti-PD-1 therapy in human melanoma.J Clin Invest2016https://conductscience.org/library/papers/27525433PubMed
828650338IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade.J Clin Invest2017https://conductscience.org/library/papers/28650338PubMed
927345472Consensus of Melanoma Gene Expression Subtypes Converges on Biological Entities.J Invest Dermatol2016https://conductscience.org/library/papers/27345472PubMed
1025970248Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity.Nature2015https://conductscience.org/library/papers/25970248PubMed
1125446897Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity.Cancer Cell2014https://conductscience.org/library/papers/25446897PubMed
1223890060The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures.Immunity2013https://conductscience.org/library/papers/23890060PubMed
1324113773Inferring tumour purity and stromal and immune cell admixture from expression data.Nat Commun2013https://conductscience.org/library/papers/24113773PubMed
1420705614Patterns of expression of DNA repair genes and relapse from melanoma.Clin Cancer Res2010https://conductscience.org/library/papers/20705614PubMed
1524894088VISTA is a novel broad-spectrum negative checkpoint regulator for cancer immunotherapy.Cancer Immunol Res2014https://conductscience.org/library/papers/24894088PubMed
1626091043Genomic Classification of Cutaneous Melanoma.Cell2015https://conductscience.org/library/papers/26091043PubMed
1721779876Prognostic impact of B-cell density in cutaneous melanoma.Cancer Immunol Immunother2011https://conductscience.org/library/papers/21779876PubMed
1826146664Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.JAMA Oncol2015https://conductscience.org/library/papers/26146664PubMed
1926317168Low numbers of tryptase+ and chymase+ mast cells associated with reduced survival and advanced tumor stage in melanoma.Melanoma Res2015https://conductscience.org/library/papers/26317168PubMed
2015534099X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization.Clin Cancer Res2004https://conductscience.org/library/papers/15534099PubMed

See all 62 referencesDownload CSV of references

Cited by71

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 83 citations.

PMIDTitleJournalYearIn PapersSource
42716012Functional characterization of the 9q34.13 locus identifies RAPGEF1 as a candidate gene modulating risk for melanoma and nevi via RAS activation.Am J Hum Genet2026https://conductscience.org/library/papers/42716012PubMed
42120944Tumor Anti-Angiogenesis Therapy and Its Influence on Immune Cell Function in the Tumor Microenvironment.Cancer Med2026https://conductscience.org/library/papers/42120944PubMed
42100918Functional characterization of the 9q34.13 locus identifies RAPGEF1 as modulating risk for melanoma and nevi via RAS activation.bioRxiv2026https://conductscience.org/library/papers/42100918PubMed
42056900Differentiation state affects PD-L1 expression in cutaneous melanoma: a systematic review.Cell Mol Biol Lett2026https://conductscience.org/library/papers/42056900PubMed
41855479LncRNA Dlx4os drives malignant transformation and phenotype switching in melanoma.Epigenetics2026https://conductscience.org/library/papers/41855479PubMed
41553603Immunotherapy in Melanoma: A Dynamic Frontier in Cancer Treatment : Author List.Curr Treat Options Oncol2026https://conductscience.org/library/papers/41553603PubMed
41542517Functional characterization of a multi-cancer risk locus on chromosome band 2q33.1 near CASP8.bioRxiv2026https://conductscience.org/library/papers/41542517PubMed
41002441Next-Generation mRNA Vaccines in Melanoma: Advances in Delivery and Combination Strategies.Cells2025https://conductscience.org/library/papers/41002441PubMed
40913277LRP2 Expression in Melanoma Is Associated With a Transitory Cell State, Increased T Cell Infiltration, and Is Upregulated by IFNy Signaling.Pigment Cell Melanoma Res2025https://conductscience.org/library/papers/40913277PubMed
39786688The Dutch Early-Stage Melanoma (D-ESMEL) study: a discovery set and validation cohort to predict the absolute risk of distant metastases in stage I/II cutaneous melanoma.Eur J Epidemiol2025https://conductscience.org/library/papers/39786688PubMed
39583094Development of mutated β-catenin gene signature to identify CTNNB1 mutations from whole and spatial transcriptomic data in patients with HCC.JHEP Rep2024https://conductscience.org/library/papers/39583094PubMed
39509669DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance.JCO Precis Oncol2024https://conductscience.org/library/papers/39509669PubMed
39098861Tumour-intrinsic endomembrane trafficking by ARF6 shapes an immunosuppressive microenvironment that drives melanomagenesis and response to checkpoint blockade therapy.Nat Commun2024https://conductscience.org/library/papers/39098861PubMed
38903502Dendritic cell subsets and implications for cancer immunotherapy.Front Immunol2024https://conductscience.org/library/papers/38903502PubMed
38341461A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC).Prostate Cancer Prostatic Dis2025https://conductscience.org/library/papers/38341461PubMed
37888209Crosstalk between Non-Coding RNAs and Wnt/β-Catenin Signaling in Head and Neck Cancer: Identification of Novel Biomarkers and Therapeutic Agents.Noncoding RNA2023https://conductscience.org/library/papers/37888209PubMed
37873189ARF6-dependent endocytic trafficking of the Interferon-γ receptor drives adaptive immune resistance in cancer.bioRxiv2023https://conductscience.org/library/papers/37873189PubMed
37586766Multimodal molecular landscape of response to Y90-resin microsphere radioembolization followed by nivolumab for advanced hepatocellular carcinoma.J Immunother Cancer2023https://conductscience.org/library/papers/37586766PubMed
37189643Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Strategies and Biomarkers Predicting Response and/or Resistance.Biomedicines2023https://conductscience.org/library/papers/37189643PubMed
36620565Frizzled receptors in melanomagenesis: From molecular interactions to target identification.Front Oncol2022https://conductscience.org/library/papers/36620565PubMed

See all 71 cited byDownload CSV of cited by

Genes48

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APC324PubTator's text mininghttps://conductscience.org/library/genes/324NCBI Gene
APC210297PubTator's text mininghttps://conductscience.org/library/genes/10297NCBI Gene
ARG1383PubTator's text mininghttps://conductscience.org/library/genes/383NCBI Gene
ARG2384PubTator's text mininghttps://conductscience.org/library/genes/384NCBI Gene
BATF355509PubTator's text mininghttps://conductscience.org/library/genes/55509NCBI Gene
BRAF673PubTator's text mininghttps://conductscience.org/library/genes/673NCBI Gene
BTLA151888PubTator's text mininghttps://conductscience.org/library/genes/151888NCBI Gene
CCL4L1388372PubTator's text mininghttps://conductscience.org/library/genes/388372NCBI Gene
CCR71236PubTator's text mininghttps://conductscience.org/library/genes/1236NCBI Gene
CD2004345PubTator's text mininghttps://conductscience.org/library/genes/4345NCBI Gene
CD27939PubTator's text mininghttps://conductscience.org/library/genes/939NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD40958PubTator's text mininghttps://conductscience.org/library/genes/958NCBI Gene
CD72971PubTator's text mininghttps://conductscience.org/library/genes/971NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CD8B926PubTator's text mininghttps://conductscience.org/library/genes/926NCBI Gene
CDH1999PubTator's text mininghttps://conductscience.org/library/genes/999NCBI Gene
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
CTNNB11499PubTator's text mininghttps://conductscience.org/library/genes/1499NCBI Gene
DKK227123PubTator's text mininghttps://conductscience.org/library/genes/27123NCBI Gene

See all 48 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29664013

GET https://conductscience.org/api/papers/v1/29664013/references?page=2